Feira de Santana starts administering antibody against RSV for premature babies or those with comorbidities
Premature babies and children with comorbidities in Feira de Santana, Brazil, can now receive the monoclonal antibody Nirsevimab to prevent severe cases of Respiratory Syncytial Virus (RSV).
Alagoas starts vaccination of newborns against bronchiolitis
Alagoas has begun administering the nirsevimab vaccine to newborns to provide immediate protection against respiratory syncytial virus (RSV), a leading cause of bronchiolitis in young children.
Maternity adopts treatment for premature babies against RSV in Cubatão; learn more
The Municipal Hospital of Cubatão starts using Nirsevimab, a monoclonal antibody, to protect premature infants from Respiratory Syncytial Virus (RSV).
Vaccine against bronchiolitis begins to be administered to newborns at Maternidade Dona Regina in Palmas
The Maternidade Dona Regina in Palmas has begun administering Nirsevimab, a monoclonal antibody that protects newborns from bronchiolitis and pneumonia, focusing on the prevention of Respiratory Syncytial Virus (RSV) complications.
New vaccine against bronchiolitis begins to be administered in the public health system of Maranhão
A new vaccine against bronchiolitis, containing the antibody Nirsevimab, has been launched in Maranhão's public health system to combat respiratory syncytial virus (RSV) infections in infants.
Medication that prevents respiratory infections in babies starts being applied on Monday (9) in Teresina
Teresina will begin administering nirsevimab to hospitalized babies and children on Monday to protect against severe respiratory infections, such as bronchiolitis and pneumonia caused by Respiratory Syncytial Virus (RSV).